Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1334713-77-7

Post Buying Request

1334713-77-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1334713-77-7 Usage

Chemical Class

Pyrrolopyrimidines

Functional Group

Tetrahydro-2H-pyran-4-yl

Potential Pharmaceutical Applications

Treatment of various diseases such as cancer and inflammation

Biological Activity

Interacts with specific molecular targets in the body

Ongoing Research

Aimed at developing new medications for managing different medical conditions

Check Digit Verification of cas no

The CAS Registry Mumber 1334713-77-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,4,7,1 and 3 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1334713-77:
(9*1)+(8*3)+(7*3)+(6*4)+(5*7)+(4*1)+(3*3)+(2*7)+(1*7)=147
147 % 10 = 7
So 1334713-77-7 is a valid CAS Registry Number.

1334713-77-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-(oxan-4-yl)-5H-pyrrolo[3,2-d]pyrimidine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1334713-77-7 SDS

1334713-77-7Relevant articles and documents

New Enzyme Inhibitor Compounds

-

, (2013/05/08)

Disclosed are compounds which inhibit SSAO enzyme activity. Also disclosed are pharmaceutical compositions comprising these compounds and the use of these compounds in the treatment or prevention of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases, immune disorders and the inhibition of tumour growth.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1334713-77-7